Search results
Unique Signatures Discovered: New Mayo Clinic Research Reveals Molecular Clues to Alzheimer’s...
SciTechDaily· 9 hours agoMayo Clinic researchers have uncovered molecular signatures of blood-brain barrier dysfunction in...
Revolutionizing Antibiotics: How MIT’s Water-Soluble Enzymes Could Change the Game
SciTechDaily· 21 hours agoScientists created a water-soluble version of an important bacterial enzyme, which can now be used...
Is killing 'zombie' cells the key to healthier aging?
AOL· 1 day agoSenescent cells were given the nickname “zombie” cells because they’re not quite dead, but they also don’t act like living cells — and they can wreak havoc on your tissues. In a new study published ...
Got a facelift and still want to look younger? Consider these options to counter aging
Miami Herald via Yahoo News· 2 days agoQ. I had a facelift approximately six months ago and I love my results. I still feel, however, that...
Q&A: Uncovering how cellular miscommunication leads to cognitive impairment in female patients with...
Medical Xpress· 2 days agoLead author Neta Rosenzweig, Ph.D., of the Brigham and Women's Hospital Ann Romney Center for...
Drugs Targeting “Zombie” Cells May Benefit Some Older Women, but Not All
Technology Networks· 2 days agoDrugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a...
Do You Really Need Sunscreen Every Day?
New York Times· 2 days agoAnd when we look up at the morning sun, our bodies recognize daytime and adjust our sleep-wake cycle accordingly. “This is one of the biggest obstacles...
Phio Pharmaceuticals Announces Reverse Stock Split
Fairview Post· 3 days agoMarlborough, Massachusetts–(Newsfile Corp. – July 2, 2024) – Phio Pharmaceuticals Corp. (Nasdaq: PHIO) (the “Company”), a clinical stage biotechnology company whose proprietary INTASYL® siRNA ...
New lab test to detect persistent HIV strains in Africa may aid search for cure
Medical Xpress· 3 days agoA multinational team led by Weill Cornell Medicine investigators developed a test that will help...
U.S. awards Moderna $176-million to advance development of its bird flu vaccine
The Globe and Mail· 3 days agoThe U.S. government has awarded $176-million to Moderna MRNA-Q to advance development of its bird...
